Panonychus Ulmi Allergy: The Orchard Spider Mite With Real IgE Data
Panonychus ulmi, the European red mite, is a spider mite pest of apple, pear, and cherry orchards with the most thoroughly documented occupational IgE sensitization data outside the house dust mite and storage mite categories — 23.2% skin prick test positivity in orchard workers, with work-related asthma in 40.4% of sensitized apple farmers versus 19.1% in non-sensitized controls. Unlike most other plant-feeding mites, P. ulmi represents a genuine occupational allergen for fruit growers requiring specialist evaluation.
Free · 5 min · Insurance accepted
Key facts
23.2% skin prick test positivity was documented for P. ulmi in apple orchard workers — work-related asthma occurred in 40.4% of sensitized vs 19.1% of non-sensitized controls.
Panonychus ulmi belongs to Tetranychidae (spider mites) — it is taxonomically unrelated to house dust mites (Pyroglyphidae) and HDM immunotherapy does not cover it.
P. ulmi is active June–August during peak orchard work season — its 0.4 mm body is visible as dark-red specks on undersides of fruit tree leaves.
Specific immunotherapy for occupational mite sensitization has a 10-year preventive effect on asthma development, supporting early treatment of orchard worker sensitization.
What Is Panonychus Ulmi and Why Does It Matter for Allergy?
Panonychus ulmi — the European red mite — is the only spider mite outside Tetranychus urticae with well-documented occupational IgE sensitization data in agricultural workers.
Belonging to the family Tetranychidae, this 0.4 mm dark-red mite is a major pest of apple, pear, cherry, and other deciduous fruit trees across temperate orchard regions of Europe, North America, and Asia. It overwinters as bright-red eggs deposited on bark and bud scars, giving orchard wood a distinctive red tinge during winter.
Unlike most plant-feeding mites that have no documented human allergy significance, P. ulmi has been confirmed to cause occupational IgE sensitization: a Spanish study documented 23.2% skin prick test positivity in apple orchard workers, and the same cohort showed work-related asthma symptoms in 40.
4% of sensitized workers versus only 19.1% of non-sensitized controls — a statistically significant difference (P<0.01).
This makes P. ulmi a genuine occupational allergen requiring consideration in any allergy evaluation of fruit orchard workers with respiratory symptoms. Most clinical allergy testing panels do not include P.
ulmi extract, meaning sensitization is frequently missed without specific occupational testing. Cross-reactivity with house dust mites has been proposed but is not well-characterized — concurrent HDM testing should be conducted alongside any P. ulmi-focused evaluation.
Symptoms of Panonychus Ulmi Occupational Allergy
Recognizing symptoms early helps you get the right treatment faster.
Occupational allergic rhinitis
moderateSneezing, nasal congestion, and clear rhinorrhea during summer orchard work in P. ulmi-infested orchards — worse during thinning and early harvest, improves when away from orchards.
Work-related asthma
moderateWheezing and chest tightness during or after orchard work in summer; 40.4% of P. ulmi-sensitized apple farmers reported work-related asthma symptoms vs 19.1% of non-sensitized controls.
Allergic conjunctivitis
mildItchy, watery eyes during high-density mite population orchard work — consistent with IgE-mediated sensitization to aerosolized mite proteins.
Contact urticaria or dermatitis
mildOccasional skin reactions in orchard workers with direct heavy mite exposure during harvest — mechanism not well-characterized.
Nocturnal asthma symptoms
moderateIn workers heavily exposed to P. ulmi during the day, late-phase allergic bronchoconstriction may cause nocturnal cough and chest tightness hours after work.
Anaphylaxis (not documented, theoretical risk)
severeAnaphylaxis has not been reported with P. ulmi exposure; however, highly sensitized workers with severe asthma should carry rescue inhalers and seek emergency care for acute severe bronchospasm.
When to see a doctor
Orchard workers sensitized to P. ulmi develop symptoms consistent with occupational rhinitis and asthma that are characteristically worse during summer orchard work and improve during winter when mite populations are absent. Work-related asthma in P. ulmi-sensitized apple farmers was documented at 40.4% versus 19.1% in non-sensitized controls — a prevalence approximately double that of unsensitized workers. Rhinitis symptoms — sneezing, nasal congestion, and watery discharge — may appear immediately upon entering infested orchard rows during peak mite season. The summer symptom peak distinguishes P. ulmi allergy from pollen allergy (spring-dominant) and HDM allergy (year-round). Anaphylaxis has not been documented with P. ulmi, but severe asthmatic reactions in highly sensitized workers during intense orchard exposure should be managed with appropriate emergency medications.
Panonychus Ulmi and Work-Related Asthma: The Published Evidence
The connection between P. ulmi sensitization and work-related asthma is the most compelling data point for this species. The Spanish study documenting 23.2% SPT positivity in apple orchard workers also found that work-related asthma symptoms were reported by 40.4% of sensitized workers compared to 19.1% of non-sensitized workers — a statistically significant excess (P<0.01). This is a substantial clinical burden: over 40% of sensitized apple farmers reported asthma symptoms during work, which is comparable to occupational asthma rates for some higher-profile industrial allergens. The mechanism likely involves IgE-mediated early-phase bronchoconstriction with possible late-phase inflammatory response in highly sensitized individuals. P. ulmi allergy does not appear to cause exercise-induced asthma symptoms independent of mite exposure — symptoms are specifically work-related, occurring in orchards during peak mite season.
Complications of Unmanaged P. Ulmi Occupational Allergy
Unmanaged P. ulmi occupational allergy in apple orchard workers carries the same risks as any unmanaged occupational asthma: progression from reversible work-related asthma to fixed airflow obstruction with years of continued high-level exposure. Work-related asthma that is not identified and managed early has a substantially worse prognosis than asthma identified promptly, because continued allergen exposure during the sensitization phase causes airway remodeling and potentially permanent lung function changes. Additionally, orchard workers who do not recognize P. ulmi allergy as their occupational exposure may inadvertently increase exposure through higher-density orchard practices (reduced IPM, more time in peak-density conditions) without understanding the health consequence.
Fixed airflow obstruction
Persistent work-related asthma from P. ulmi exposure, if unmanaged for years, can progress to irreversible airway remodeling and fixed obstruction.
Career limitation in orchard work
Severely sensitized workers may need to avoid orchard work entirely during peak mite season, which is also the economically critical summer labor period.
Polysensitization to co-occurring allergens
Without immunotherapy, P. ulmi-sensitized workers may progressively sensitize to additional occupational allergens (grass pollens, mold) over continued work seasons.
How Panonychus Ulmi Causes Occupational Allergy
The proposed mechanism for P. ulmi occupational sensitization is inhalation of aerosolized mite body fragments and fecal particles during high-intensity orchard work — pruning, thinning, and harvest operations in summer when mite populations peak.
European red mite (primary page subject)
Panonychus ulmi
Citrus red mite (related species on citrus)
Panonychus citri
Two-spotted spider mite (~30% SPT in greenhouse workers)
Tetranychus urticae
How it works
Panonychus ulmi is presumed to sensitize through IgE-mediated mechanisms similar to other occupational mite allergens — repeated inhalation of aerosolized proteins leads to antigen presentation to T helper cells, Th2 cytokine production (IL-4, IL-13), B-cell class switching to IgE, and subsequent mast cell/basophil sensitization. Upon re-exposure, mast cell degranulation releases histamine and prostaglandins, producing allergic rhinitis and bronchoconstriction. Whether P. ulmi shares cross-reactive epitopes with Der p 1 or Der p 2 through shared invertebrate proteins (e.g., tropomyosin group 10 allergens) has not been well-characterized in the published literature.
At population densities that can reach several hundred mites per leaf during outbreak conditions, P. ulmi generates substantial quantities of protein-containing biological material that can become airborne in the orchard canopy.
Workers walking through infested rows, applying treatments, or harvesting in close contact with infested foliage have repeated mucosal exposure to these aerosolized materials. Sensitization accumulates over repeated seasons of occupational exposure, explaining why SPT positivity rates are higher in long-term orchard workers than in those with shorter tenure.
The mite's overwintering egg strategy is unusual among Tetranychidae — eggs are deposited on bark and bud scars in autumn, surviving winter to hatch in spring, which creates a distinctive exposure pattern that differs from the year-round mite cycle of house dust mites.
Risk factors to watch for
Fruit orchard employment
Apple, pear, and cherry orchard workers are the primary at-risk population; sensitization rates increase with years of orchard employment.
Summer orchard work (June–August)
P. ulmi population peaks in summer correlate with the highest mite fragment aerosolization exposure during pruning, thinning, and early harvest.
Atopic constitution
Pre-existing atopy (hay fever, eczema, asthma) increases susceptibility to occupational mite sensitization in apple orchard workers.
Organic or low-spray orchards
Orchards with reduced acaricide use may have higher P. ulmi mite densities, potentially increasing orchard worker allergen exposure.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing P. Ulmi Occupational Allergy: Specialist Evaluation Required
Diagnosing P. ulmi occupational allergy requires a specialist allergist familiar with agricultural occupational allergens — P. ulmi is not included in standard commercial allergy panels. The clinical history is crucial: symptoms predominantly in summer, worse in apple or pear orchards during mite population peaks, improving during winter off-season or after orchard work cessation. Serial peak flow measurements at work and away from work over 2–4 weeks provide objective confirmation of work-related asthma. Skin prick testing requires specialized P. ulmi mite extract, available in some academic allergy centers in Europe (particularly Spain, Germany, and the Netherlands where most research has occurred) but not widely commercially available. Specific IgE blood testing to P. ulmi extract may be available in specialized occupational allergy laboratories. Standard dust mite testing should be conducted simultaneously to assess concurrent HDM sensitization. At-home allergy testing services such as Curex offer panels covering 40+ environmental allergens including standard indoor allergens and storage mites, which helps establish the concurrent indoor allergen baseline while occupational P. ulmi testing is arranged through a specialist.
Serial Peak Flow Monitoring
Recording peak expiratory flow multiple times daily at work and away from work for 2–4 weeks; a >15–20% reduction during orchard work in summer confirms work-related asthma from P. ulmi or other occupational allergens.
Skin Prick Test — Panonychus Ulmi Extract (Specialist Centers)
Specialized P. ulmi mite extract applied via skin prick; available at academic occupational allergy centers in Europe. Positive wheal confirms IgE-mediated sensitization.
Standard Aeroallergen Panel (Concurrent Testing)
Standard D. pteronyssinus, D. farinae, Lep d 2, grass pollens, and mold testing to assess concurrent sensitization alongside any P. ulmi-specific evaluation.
Pulmonary Function Testing
Spirometry and diffusion capacity to quantify airflow obstruction and monitor for progression in workers with established work-related asthma from orchard exposure.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizManaging P. Ulmi Occupational Allergy in Apple Orchard Workers
See how different approaches stack up for managing your allergy symptoms long-term.
Management of P. ulmi occupational allergy combines targeted mite population control in the orchard (reducing exposure at the source), personal respiratory protection during peak exposure seasons, and standard allergic rhinitis and asthma pharmacotherapy. Orchard workers with confirmed P. ulmi sensitization and work-related asthma should be managed by both an occupational allergist and a pulmonologist. IPM strategies that reduce P. ulmi populations through predatory mites (Typhlodromus pyri — a naturally occurring predatory mite in European orchards) and reduced broad-spectrum acaricide use benefit both crop management and worker health.
IPM and Predatory Mite Programs (Exposure Reduction)
Maintaining Typhlodromus pyri predatory mite populations in apple orchards through selective pesticide use reduces P. ulmi densities, limiting worker aeroallergen exposure. This European IPM standard practice benefits both crop protection and occupational health.
N/A
Well-documented agronomic approach that maintains P. ulmi below economic thresholds in European orchards; reduces peak season allergen exposure
N95 Respirators During Peak Mite Season
Wearing N95 respirators during summer orchard work (thinning, treatment, early harvest) in infested orchards reduces inhalation of aerosolized P. ulmi mite fragments and feces.
N/A
N95 respirators filter >95% of particles ≥0.3 μm; reduces mite fragment inhalation substantially
Intranasal Corticosteroids
First-line treatment for P. ulmi-triggered occupational rhinitis; most effective when started before peak mite season.
Flonase (fluticasone), Nasacort (triamcinolone), Rhinocort (budesonide)
Studies show 50–70% reduction in rhinitis symptom scores with daily use
Antihistamines
Second-generation antihistamines provide rhinitis and conjunctivitis symptom relief during P. ulmi exposure seasons.
Zyrtec (cetirizine), Claritin (loratadine), Allegra (fexofenadine)
Effective for rhinitis and conjunctivitis symptoms; less effective for asthma
Inhaled Corticosteroids and Short-Acting Beta-Agonist (for Work-Related Asthma)
Standard asthma controller therapy for orchard workers with confirmed work-related asthma from P. ulmi sensitization; rescue bronchodilator for acute episodes in the orchard.
Advair (fluticasone/salmeterol), albuterol (rescue)
Evidence-based standard of care for work-related allergic asthma
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for P. Ulmi Occupational Allergy: An Emerging Option
Instead of masking symptoms, immunotherapy retrains your immune system.
No standardized or FDA-approved immunotherapy protocol exists specifically for P. ulmi allergy — the occupational research documentation is primarily from Spanish and European academic centers, and no commercial P. ulmi allergen extract is widely available for immunotherapy formulation. However, for orchard workers with P. ulmi sensitization and concurrent HDM sensitization (which is clinically plausible given Tetranychidae/Pyroglyphidae invertebrate protein cross-reactivity), standard HDM immunotherapy may provide partial benefit. The definitive treatment for true P. ulmi-specific sensitization would require custom SLIT drops incorporating P. ulmi extract, available in specialized European occupational allergy centers. For the concurrent indoor allergen component, sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), can address house dust mite and other standard environmental allergen sensitizations conveniently at home. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026, peer-reviewed), clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, adherence was over 90%, and no anaphylaxis was reported. The most important clinical step is obtaining a precise diagnosis at an occupational allergy specialist center before attempting any P. ulmi-specific immunotherapy, as no commercial standardized extract exists for routine clinical use.
Specialist Occupational Allergy Evaluation
Evaluation by an occupational allergist familiar with P. ulmi; serial peak flow monitoring and P. ulmi extract SPT at a center with research-grade materials.
Concurrent HDM Assessment
Standard indoor allergen testing including CRD (Der p 1, Der p 2) to identify any co-existing HDM sensitization that standard ODACTRA or SLIT can address.
IPM Exposure Reduction in Orchard
Implementing Typhlodromus pyri predatory mite programs to reduce P. ulmi densities — essential alongside any immunotherapy as exposure reduction is the primary intervention.
Custom Immunotherapy if Available
Specialist centers may formulate P. ulmi SLIT for confirmed occupational sensitization; standard indoor allergen SLIT addresses co-sensitizations at $39/month.
“No published RCT data for P. ulmi-specific immunotherapy; occupational allergen immunotherapy evidence extrapolated from spider mite and HDM studies showing 60–85% symptom reduction”
Treat your Panonychus Ulmi allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living and Working in Orchards With P. Ulmi Allergy
Apple, pear, and cherry orchard workers with confirmed P. ulmi sensitization face the practical challenge that their peak allergen exposure coincides with their economically most critical work season (summer). Unlike pollen allergy where seasonal avoidance is sometimes feasible, orchard workers cannot readily avoid orchard work in June–August without significant economic impact. The most practical approach combines IPM to reduce population densities, N95 respirators during high-density mite work, and pharmacological symptom control. Some long-term orchard workers with severe sensitization have successfully transitioned to management roles that reduce their direct canopy work time during peak season. Early immunotherapy initiation before work-related asthma becomes severe offers the best chance of sustained orchard career participation.
IPM benefits your lungs as well as your crop
Maintaining Typhlodromus pyri in your apple orchard reduces P. ulmi populations year over year — each successful predatory mite season is also a season of lower worker allergen exposure during thinning and harvest.
Summer symptoms are a diagnostic clue
If your respiratory symptoms are specifically worst in July and August in the orchard and improve in winter, P. ulmi sensitization is a plausible explanation worth specialist evaluation — even if standard allergy panels have been normal.
Carry rescue medication during harvest
Orchard workers with known asthma from P. ulmi sensitization should carry a short-acting bronchodilator during peak season orchard work in case of acute bronchoconstriction in infested orchard conditions.
Seasonal Pattern of P. Ulmi Exposure in Orchards
Panonychus ulmi has a well-defined seasonal exposure pattern that directly tracks the orchard growing calendar. Overwintering eggs begin hatching in spring (March–April in temperate Northern Hemisphere) as apple buds break. Summer morph populations build through late spring and peak in June–August, when temperatures are highest and populations can reach outbreak levels without adequate IPM. Populations decline in autumn as females shift to producing overwintering eggs. The highest orchard worker allergen exposure therefore occurs during summer — the same period as fruit thinning and early harvest operations when workers spend maximum time among infested foliage. This summer peak distinguishes P. ulmi allergy from house dust mite allergy, which is year-round, and from pollen allergy, which peaks in spring.
March - May
low intensity
June - August
high intensity
September - November
medium intensity
December - February
low intensity
Preventing P. Ulmi Exposure and Sensitization in Orchards
Prevention of P. ulmi occupational allergy centers on maintaining mite populations below sensitization-risk densities through IPM, using respiratory protection during high-density mite work, and identifying sensitization early before work-related asthma becomes established.
Maintain Typhlodromus pyri in orchards
This naturally occurring predatory mite is the cornerstone of European apple orchard IPM for P. ulmi control — preserving it through selective pesticide choices keeps P. ulmi populations at low densities that also reduce worker allergen exposure.
Wear N95 respirators in June–August
Peak mite season coincides with peak summer harvest preparation — N95 respirators during thinning, spraying, and early harvest reduce mite fragment inhalation.
Pre-season pulmonary function testing
Annual spirometry for long-term apple orchard workers allows early detection of airflow obstruction developing from P. ulmi work-related asthma, enabling treatment before irreversible damage occurs.
Monitor orchard mite population weekly
Conducting regular leaf wash counts or hand lens surveys in summer identifies P. ulmi population buildups requiring intervention before densities reach levels associated with highest worker allergen exposure.
Avoid broad-spectrum acaricide use
Organophosphate and pyrethroid acaricides kill Typhlodromus pyri predators as effectively as P. ulmi, eliminating natural population control and leading to mite resurgence — worst outcome for both crop and worker.
Prognosis for Apple Orchard Workers With P. Ulmi Allergy
The prognosis for P. ulmi-sensitized orchard workers depends critically on when the diagnosis is made and how promptly IPM exposure reduction and treatment are implemented. Work-related asthma identified in its early, reversible phase — when symptoms are purely work-related with normal off-work lung function — has excellent prognosis with proper management. Once fixed airflow obstruction develops from years of unmanaged high-level exposure, functional outcomes are more limited. Long-term orchard career participation is feasible for most sensitized workers who implement effective IPM, respiratory protection, and pharmacological management. The unique feature of P. ulmi allergy — its strong summer-winter symptom cycle — also creates natural disease management opportunities during the winter off-season when lung function can fully recover with reduced mite exposure.
Key takeaways
Panonychus ulmi is the only spider mite outside Tetranychus urticae with documented 23.2% SPT positivity and work-related asthma data in orchard workers
IPM that maintains Typhlodromus pyri predatory mite populations reduces P. ulmi densities, lowering orchard worker allergen exposure alongside crop protection benefits
Early work-related asthma identification before fixed obstruction develops yields the best prognosis for continued orchard career participation
Diet and Panonychus Ulmi Allergy: Potential Cross-Reactivities
No specific dietary restrictions have been established for P. ulmi-sensitized orchard workers. However, like all spider mites in the Tetranychidae family, P. ulmi contains invertebrate tropomyosin — the pan-allergen linking mites to shellfish. If a P. ulmi-sensitized orchard worker also has IgE to tropomyosin (group 10 allergen), theoretical cross-reactivity with shrimp and other crustaceans may occur. Component testing (specific IgE to shrimp tropomyosin Pen a 1) can clarify whether dietary shellfish restriction is clinically indicated. Oral mite anaphylaxis from P. ulmi-contaminated agricultural products is not documented — unlike storage mites in flour, P. ulmi does not contaminate food products in consumed quantities.
Foods that help
Omega-3 fatty acids (salmon, mackerel)
Anti-inflammatory dietary fats may modestly support systemic anti-inflammatory balance in allergic individuals, though direct evidence for P. ulmi allergy specifically is not established.
Foods to limit
Shellfish (if tropomyosin IgE positive)
Spider mite tropomyosin cross-reacts with shrimp tropomyosin (Pen a 1) at ~80–95% sequence identity; component testing can confirm whether P. ulmi-sensitized workers face shellfish allergy risk.
Fruit orchard workers with respiratory symptoms deserve specific testing for Panonychus ulmi, not just a standard HDM panel — this spider mite has the strongest occupational allergy evidence of any plant-feeding mite and is completely missed by panels that don't include orchard mite extracts.
Frequently Asked Questions
The strongest evidence comes from a Spanish study of apple orchard workers that documented 23.2% skin prick test positivity to P. ulmi mite extract. In the same cohort, work-related asthma symptoms were present in 40.4% of SPT-positive workers versus only 19.1% of SPT-negative workers — a statistically significant difference (P<0.01). European orchard research in Germany and the Netherlands has produced corroborating occupational health observations. These data place P. ulmi in a small group of plant-feeding mites with documented occupational IgE sensitization, alongside Tetranychus urticae (two-spotted spider mite) with approximately 30% SPT positivity in greenhouse workers. Most other plant-feeding mites have no comparable human allergy data.
Medical References
- [1]Sánchez-Borges M, Fernández-Caldas E, Thomas WR, et al. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017;10:14.
- [2]Arlian LG, Platts-Mills TAE. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol. 2001;107:S422-S429.
- [3]WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen Nomenclature Database. Available at: allergen.org. Accessed 2025.
- [4]Quirce S, Vandenplas O, Campo P, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71:765-779.
- [5]Resch Y, Weghofer M, Bauer R, et al. Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy. 2011;41:1468-1477.
- [6]American College of Allergy, Asthma & Immunology (ACAAI) — Occupational Asthma
- [7]Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943-948.
- [8]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [9]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Panonychus Ulmi allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.
